Rapid Identification of Hospitalized Patients at High Risk for MRSA Carriage

Autor: Matthew H. Samore, James F. Lloyd, Amyanne Wuthrich, Rouett Abouzelof, R. Scott Evans, Kyle V. Johnson, Carrie Jane Wallace, Caroline W. Taylor, Stéphan Juergen Harbarth, Sharon Sumner

Publikováno v: Journal of the American Medical Informatics Association, Vol. 15, No 4 (2008) pp. 506-12

Patients who are asymptomatic carriers of methicillin-resistant Staphylococcus aureus (MRSA) are major reservoirs for transmission of MRSA to other patients. Medical personnel are usually not aware when these high-risk patients are hospitalized. We d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6abdcddfa041647e4b5ea775207c5ef3
http://doc.rero.ch/record/289684/files/15-4-506.pdf

Which anatomical sites should be sampled for screening of methicillin-resistant Staphylococcus aureus carriage by culture or by rapid PCR test?

Autor: Patrick Basset, Dominique S. Blanc, Giorgio Zanetti, I. Nahimana, Laurence Senn

Publikováno v: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, vol. 18, no. 2, pp. E31-3

The nose is the anatomical site usually recommended for methicillin-resistant Staphylococcus aureus (MRSA) screening. Other sites are also recommended, but are more controversial. We showed that the sensitivities of MRSA detection from nasal swabs al

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6390932187ffe5e302cd848dae4eb50d
https://doi.org/10.1111/j.1469-0691.2011.03724.x

Cost-effectiveness of universal MRSA screening on admission to surgery

Autor: G. De Angelis, Didier Pittet, Ilker Uçkay, Jacques Schrenzel, Stéphan Juergen Harbarth, A. Murthy

Publikováno v: Clinical Microbiology and Infection, Vol. 16, No 12 (2010) pp. 1747-1753

Policy-makers have recommended universal screening to reduce nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection. Risk profiling of MRSA carriers and rapid PCR tests are now available, yet cost-effectiveness data are limited. The

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e53014ae731ddfd4cf75cdce155615d
https://archive-ouverte.unige.ch/unige:21159

Absence of Chronic Human Immunodeficiency Virus Infection without Seroconversion in Intravenous Drug Users: A Prospective and Retrospective Study

Autor: Jean-Jacques Déglon, Sabine Yerly, Eric Chamot, Bernard Hirschel, Luc Perrin

Publikováno v: The Journal of Infectious Diseases, Vol. 164, No 5 (1991) pp. 965-968

It has been reported that human immunodeficiency virus type 1 (HIV-1) infection may exist in persons without specific antibodies for years. To measure the frequency of a silent carrier state, a study was conducted in a cohort of 124 intravenous drug

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2e46dde6acf12bb721ec88acb3034e9
https://doi.org/10.1093/infdis/164.5.965

Evaluating the probability of previously unknown carriage of MRSA at hospital admission

Autor: Didier Pittet, Jacques Schrenzel, Stéphan Juergen Harbarth, Americo Agostinho, Carolina Fankhauser-Rodriguez, Hugo Sax

Publikováno v: American Journal of Medicine, Vol. 119, No 3 (2006) pp. 275 e215-223

Purpose We determined the prevalence and risk profile of patients with previously unknown carriage of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission. Subjects and methods We conducted a 7-month, prospective case-controlled s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fff064118174ba8fec0abc1d6dc27ef
https://archive-ouverte.unige.ch/unige:7306